Aptadir Therapeutics, a biotech focused on RNA inhibitor therapies for cancer and genetic conditions, has launched with $1.6 ...

Telix Pharmaceuticals is acquiring US-based RLS Radiopharmacies for $230 million upfront, plus $20 million in performance ...

Shares in San Diego-based inflammatory diseases specialist Ventyx Biosciences (Nasdaq: VTYX) rose 8.7% to $2.50 yesterday as ...

The Association of the British Industry (ABPI) and the Prescription Medicines Code of Practice Authority (PMCPA) have ...

Israeli drugmaker Teva Pharmaceuticals presented new research at the European College of Neuropsychopharmacology, including ...

Two new studies highlight the pharmaceutical sector's crucial role in Greece's economy. The first, The Market in Greece: ...

German privately-held biotech ARTCLINE Bio-Therapies today announced the appointment of Dirk Hessel as additional managing ...

The US Food and Drug Administration (FDA) has approved Bimzelx (bimekizumab-bkzx) for the treatment of adults with active ...

Shares of California, USA-based precision medicines IDEAYA Biosciences were down 6.3% at $32.5 mid-morning after it revealed ...

The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended approval of Hetronifly ...

The Health Sciences Authority (HSA) of Singapore has approved Merck & Co’s Winrevair (sotatercept), for the treatment of ...

British biotech Vicebio has secured $100 million in a series B funding round to advance its next-generation vaccines against ...